Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Vaccine Production

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

Vaccines

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Vaccinations

Vaccinations

Preclinical Development: Overview

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

Bioequivalence studies: Biowaivers

Bioequivalence studies: Biowaivers

In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same journal

Court finds no Vaccines-autism link.

Human vaccines·2022

Same journal

Introduction of a second dose of measles in national immunization program in India: a major step towards eradication.

Human vaccines·2012

Same journal

Vaccination against trypanosomiasis: can it be done or is the trypanosome truly the ultimate immune destroyer and escape artist?

Human vaccines·2011

Same journal

Immune response to influenza vaccination in children treated with methotrexate or/and tumor necrosis factor-alpha inhibitors.

Human vaccines·2011

Same journal

Safety and immunogenicity of a modified process hepatitis B vaccine in healthy adults ≥50 years.

Human vaccines·2011

Same journal

Fighting against infectious diseases in China.

Human vaccines·2011

Search research articles

Related Experiment Video

Updated: Jul 6, 2026

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

Collaborative vaccine development: partnering pays.

Rangappa Ramachandra¹

¹ImmunoTechnologies, Covance Research Products, Denver, Pennsylvania 17517 , USA. rangappa.ramachandra@Covance.com

|April 5, 2008

Summary

Vaccine development is booming, driven by global health needs and new technologies. Partnering with specialized contract research organizations (CROs) accelerates vaccine innovation and market entry.

Area of Science:

Life Sciences
Immunology
Biotechnology

Background:

The vaccine sector is experiencing significant growth, fueled by unmet medical needs and emerging threats.
Traditional manufacturing methods are evolving, with new processes enhancing vaccine optimization.
Increased demand stems from global health challenges, antimicrobial resistance, bioterrorism concerns, and preventive care for diverse populations.

Purpose of the Study:

To highlight the critical role of efficient study conduct in accelerating vaccine development.
To emphasize the benefits of strategic partnerships with specialized contract research organizations (CROs).
To outline key functions and advantages of outsourcing in vaccine research and development.

Main Methods:

Leveraging specialized Contract Research Organizations (CROs) with expertise in immunology and adaptable scientific strategies.

More Related Videos

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

Related Experiment Videos

Last Updated: Jul 6, 2026

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

Outsourcing key development functions including animal model creation, safety and efficacy trials, immunotoxicity, immunogenicity, dose-response studies, and stability/potency testing.

Focusing on collaborative research models that enhance flexibility and optimize resource allocation.

Main Results:

Partnerships with CROs provide objective assessments of success probability and alternative development pathways.
Outsourcing reduces infrastructure costs and allows vaccine developers to concentrate on core innovations.
Collaborations streamline development, reduce redundancies, and expedite time-to-market for new vaccines.

Conclusions:

Strategic outsourcing to specialized CROs is crucial for efficient and timely vaccine development.
Effective partnerships, characterized by clear communication and flexibility, are key to navigating the complexities of vaccine R&D.
CROs offer essential scientific, regulatory, and technical expertise, enhancing the overall vaccine development lifecycle.